Skip to main navigation
Skip to search
Skip to main content

University of Luebeck Home

- English
- Deutsch

Home
Research Units
Experts
Publications
Projects
Prizes
Spin-Offs
Activities
Media

Search by expertise, name or affiliation

Prognostic Value of Blood Biomarkers in Steroid-Refractory/Dependent Acute Graft-vs-Host Disease: A REACH2 Analysis: a REACH2 analysis

REACH2 investigators

Clinic of Hematology and Oncology
Luebeck Integrated Oncology Network (LION)

Université Paris Descartes
University of Leipzig
AP-HP Assistance Publique - Hopitaux de Paris
Peter Maccallum Cancer Centre
Hebrew University of Jerusalem
Novartis Pharma S.A.S.
Novartis Pharma AG
University of Freiburg

Overview
Fingerprint

Fingerprint

Dive into the research topics of 'Prognostic Value of Blood Biomarkers in Steroid-Refractory/Dependent Acute Graft-vs-Host Disease: A REACH2 Analysis: a REACH2 analysis'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Medicine & Life Sciences

Powered by Pure, Scopus & Elsevier Fingerprint Engine™

All content on this site: Copyright © 2024 Elsevier B.V. or its licensors and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the Creative Commons licensing terms apply

We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies

About web accessibility

Report vulnerability